Th1 and Th2 cells characterized by IFN-γ and IL-4 production respectively are increased in the blood of CLL patients compared to healthy controls and Th1 cells are even higher in progressive disease (137). This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.